Irofulven in Treating Patients With Metastatic Colorectal Cancer
Status:
Completed
Trial end date:
2000-11-08
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of irofulven in treating patients with
metastatic colorectal cancer.